In patients with community-acquired pneumonia, the incidence of acute respiratory distress syndrome based on the Berlin definition was 2% among all patients in hospital, 13% among patients in intensive care, and 29% among patients receiving mechanical ventilation. Acute respiratory distress syndrome was not related to the aetiology or mortality in this population.
INTRODUCTION
Community-acquired pneumonia (CAP) is associated with increased morbidity, mortality, and health costs [1, 2] . The incidence of severe CAP requiring intensive care unit (ICU) admission is increasing, both because of septic shock and the need for invasive mechanical ventilation (IMV) [3] . Despite global efforts to improve outcomes, mortality remains high in severe CAP [4] [5] [6] . Streptococcus pneumoniae is the leading cause of CAP; it is the underlying etiological agent in 22% of patients requiring ICU admission [7] , and approximately 30% of these patients develop pulmonary complications during their clinical courses [8] .
Acute respiratory distress syndrome (ARDS) is a potential complication of severe CAP that is reported in approximately 3% of patients hospitalized with pneumococcal CAP [9] . This condition is characterized by the rapid development of severe acute respiratory failure, and is associated with high morbidity and mortality despite advances in supportive care and ventilator management [10, 11] . However, there is limited information regarding the incidence of ARDS, associated pathogens, risk factors, and specific outcomes in hospitalized patients with severe CAP, especially in the era of the current Berlin definition, according to which patients must be receiving positive-pressure ventilation [12] . Although the overall survival from ARDS is improving [12, 13] , mortality remains as high as 35%, and disabling complications persist among ICU survivors, with recovery sometimes continuing for more than one year [13, 14] . In addition, ARDS may be under recognized and undertreated [14] .
We hypothesized that patients with severe CAP and ARDS have a higher mortality than those patients who require mechanical ventilation without ARDS. The aim of the study was to assess the incidence, clinical characteristics, aetiology, risk factors and mortality of ICU patients with severe CAP and ARDS according to the new Berlin definition [12] , compared with ventilated patients without ARDS.
METHODS

Study design and patients
Please refer to the online Supplemental Material for full details of the methods. This was a prospective observational cohort study of consecutive adult patients with CAP admitted to the ICU within 24 hours of hospital admission, between November-1996 and December-2016. The inclusion criteria were as follows: 1) met the criteria for severe CAP [15] and were admitted to the ICU, which included intermediate care units; and 2) received either IMV or non-invasive mechanical ventilation (NIMV) during the first 24 hours of hospital admission. Patients were excluded if they had severe immunosuppression or active tuberculosis. [22] were used to examine the associations between ARDS and risk factors. First, each risk factor was tested individually. Second, all risk factors with an association in the univariate model (p < 0.15) were added to the multivariate model. Finally, a backward stepwise selection (p in < 0.05, p out < 0.10) was used to determine factors associated with ARDS. The association with 30-day mortality was tested by univariate and multivariate analyses with the same inclusion criterion (p < 0.15).
Logistic regression analyses
A propensity score was developed for patients with ARDS [23] . Together with the year of occurrence of pneumonia, the presence of ARDS, the microbial aetiology, and the interaction between ARDS and the microbial aetiology, this was incorporated into the multivariate logistic regression analysis to predict 30-day mortality. If two independent variables were highly correlated (r > |±0.30|), the variable with the largest variance was excluded from multivariate analysis [24] . The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.
The Hosmer-Lemeshow goodness-of-fit test was performed to assess the overall fit of the models. The areas under the receiver operating characteristic curves (AUCs) of the multivariate models were calculated to predict ARDS and 30-day mortality. Internal validation of the prediction models was conducted by ordinary nonparametric bootstrapping with 1,000 bootstrap samples and bias-corrected, accelerated 95% CIs [25] . The same analyses were performed on the subset of patients with pneumococcal CAP. Finally, we used multiple imputation [26] to handle missing data.
RESULTS
Patients' characteristics
Among 5,334 patients hospitalized with CAP during the observation period, 930 (17%) were admitted to the ICU, of whom 462 (52%) were not ventilated, 137 (15%) received NIMV, and 295 (33%) received IMV ( Figure 1 ).
The study population comprised 432 patients treated in ICU with either IMV or NIMV: 125 cases (29%) met the Berlin ARDS criteria, and 307 cases (71%) did not. ARDS was present in 2% of all patients hospitalized with CAP and in 13% of those admitted to the ICU. According to the severity classification based on the baseline PaO 2 /FiO 2 ratio, 60 (48%), 49 (40%), and 15 (12%) patients had mild, moderate, and severe ARDS, respectively. Two patients had been ventilated in the prone position. None of them had received extracorporeal membrane oxygenation.
The patients' characteristics are shown in Tables 1 and 2. Compared to patients without ARDS, those with ARDS had less frequently received treatment with inhaled corticosteroids; had less chronic respiratory co-morbidity, particularly COPD; had poorer baseline oxygenation, higher organ dysfunction, and lower PSI risk; and had more multilobar involvement. However, there was only a trend to have less frequently received pneumococcal vaccination, for less frequent male gender, and more frequent prior antibiotic treatment.
Microbiological diagnosis
An etiologic diagnosis was obtained in 228 patients (53%; Table 3 ). The most frequent pathogen in both groups was S. pneumoniae, with no significant differences in aetiology between the groups. Among the 100 cases of pneumococcal CAP, 29 met the ARDS criteria, the same proportion as in the overall population.
Empiric antibiotic therapy
Data on empiric antibiotic treatment were available in 414 patients (96%; Online Table 1 ). The most frequent regimens were ß-lactam plus either a respiratory fluoroquinolone (42%) or a macrolide (31%). ARDS patients more often received a ß-lactam plus a respiratory fluoroquinolone compared with non-ARDS patients (p=0.003).
Predictors of ARDS
Among the variables associated with ARDS in the univariate analysis (Table 4 ), a higher SOFA score and previous antibiotic treatment remained significant independent risk factors for ARDS in the multivariate analysis. Interestingly, prior treatment with inhaled corticosteroids was independently associated with a lower risk for ARDS. The AUC was 0.66 (95% CI, 0.60-0.71) for the model predictive of ARDS (Online Figure 1 ). Internal validation of the logistic regression model by bootstrapping demonstrated robust results for all the variables in the model, with small 95% CIs around the original coefficients (Online Table 2 ).
Mortality and length of stay
We did not find significant differences between groups regarding mortality or length of hospitalization (Table 5 ). However, in cases with pneumococcal CAP, mortality in ICU was higher among those with ARDS (p=0.026; Online Table 3 ), but neither the in-hospital mortality (p=0.070) nor the 30-day mortality (p=0.088) reached statistical significance.
According to ARDS severity, the 30-day mortality rate was 32%, 33%, and 60% for patients with mild, moderate and severe ARDS, respectively.
Predictors of 30-day mortality
Among the different variables associated with 30-day mortality in the univariate analysis (Table 6 ), the following were independent predictors of 30-day mortality in the propensity-adjusted multivariate analysis: older age, previous antibiotic treatment, other chronic pulmonary diseases (including only the sequelae of pulmonary tuberculosis, pulmonary hypertension, and interstitial lung disease), chronic cardiovascular and liver disease, higher SOFA score, and inadequate empiric antibiotic treatment. It was notable that having a previous episode of pneumonia and having received the pneumococcal vaccination were independently associated to a reduced 30-day mortality rates.
Overall, ARDS was not associated with 30-day mortality, even after adjustment for potential confounders. The AUC was 0.79 (95% CI, 0.75-0.84) for the model predictive of 30-day mortality (Online Figure 2 ). Internal validation of the logistic regression model by bootstrapping with demonstrated robust results for all variables included in the model, with small 95% CIs around the original coefficients. Finally, the same analysis in the subset of patients with pneumococcal CAP confirmed that ARDS was not independently associated with 30-day mortality after adjustment for potential confounders (adjusted OR, 1.77; 95% CI, 0.70-4.50; p=0.23).
DISCUSSION
The main findings of this study are as follows. First, based on the Berlin definition, ARDS was present in 2% of all hospitalized patients with CAP, 13% of those admitted to the ICU, and 29% of those ICU patients requiring mechanical ventilatory support. Second, higher SOFA scores and previous antibiotic use were independent predictors for ARDS among ventilated patients with CAP, while previous inhaled corticosteroid treatment was protective. Third, ARDS had no different aetiologies or mortality in patients requiring mechanical ventilation for CAP.
ARDS is recognized globally as a major clinical problem [13] , with pneumonia and extrapulmonary sepsis being the main risk factors in 75% of cases [14] . However, there has been a lack of information about the incidence of ARDS in CAP after the Berlin definition was proposed. Our data are consistent with those of the LUNG SAFE study [14] , which evaluated the incidence of ARDS in 459 ICUs in 50 countries. They reported that ARDS occurred in 10% of all ICU admissions and in 23% patients who required mechanical ventilation. According to the Berlin criteria, 30%, 47%, and 23% of their patients had mild, moderate, and severe ARDS, respectively. By contrast, there was a higher proportion of mild ARDS and a lower proportion of severe ARDS in our cohort.
Over the past century only a few small case series of ARDS in pneumococcal CAP have been reported [27] [28] [29] . A recent French multicenter study [30] concerning pneumococcal CAP in the ICU indicated that the incidence of ARDS was 45%, which was substantially higher than that reported in this study. However, those authors used the prior American-European consensus definition of ARDS [31] and not the current Berlin definition, and included non-ventilated patients (16%).
To our knowledge, this is the first study to provide data on the incidence of ARDS using the Berlin definition among patients hospitalized with CAP. We studied a cohort with severe CAP requiring mechanical ventilation, and compared those with and without ARDS. Regarding the independent predictors for ARDS, the association of higher organ system dysfunction to ARDS was to be expected because these patients had worse baseline oxygenation, an important component of the score.
We previously reported that inhaled corticosteroid use before admission in patients hospitalized because of CAP can reduce the systemic inflammatory response [32] , possibly with a selective modulation of the mechanisms of defences to infection [33] , with reduced serum levels of tumour necrosis factor (TNF)-alpha, among others. This biomarker has been involved in the pathophysiology of ARDS [34] .
We have no clear explanation for the independent association between previous antibiotic use and increased risk of ARDS. To our knowledge, this association has not previously been reported. We have shown that previous antibiotic use can be associated with antibiotic-resistant bacteraemia in patients with CAP [35] , resulting in more inappropriate therapy. Whether this could predispose patients to ARDS remains to be assessed. However, this association requires confirmation in future studies.
Mortality among ARDS patients was no different to that among ventilated non-ARDS patients. Indeed, even the propensity-adjusted multivariate analysis did not show an association between ARDS and patients' mortality. According to our results, we think that the expected association of ARDS with mortality seems more related to the need for mechanical ventilation in these patients with CAP rather than ARDS itself, as we have recently reported that invasive mechanical ventilation in patients with severe CAP independently predicts mortality [36] . However, we cannot exclude that specific populations of patients with CAP and ARDS may have different mortality, since sub-phenotypes of ARDS patients with different outcomes related to inflammation [37] or fluid responsiveness [38] have recently been proposed.
Independent predictors of mortality have previously been reported for CAP and other pulmonary infections in critically-ill patients, including older age, chronic liver disease [39] , chronic cardiovascular disease [39] [40] [41] , increased organ system dysfunction [42] [43] [44] , and inadequate empiric treatment [45] . It is not clear the reason for the association of previous pneumonia with lower mortality; possibly these patients might have developed a more effective immune response to infection. This is also consistent with pneumococcal vaccination being independently associated with reduced mortality. Given that ARDS was related to mortality in patients with pneumococcal pneumonia, previous vaccination might reduce disease severity in these patients.
Due to the association of ARDS with higher mortality in pneumococcal pneumonia, there is a need to develop effective preventive measures for this complication. A recent randomized clinical trial [46] and a meta-analysis [47] found that short-term treatment with corticosteroids can prevent radiographic progression and ARDS development in CAP. However, these studies investigated CAP in general, not pneumococcal pneumonia specifically. Studies focusing on the acute treatment of pneumococcal pneumonia with corticosteroids or other immunomodulators [48] are therefore needed. Unfortunately, we have no systematic data on the number of patients who received pneumococcal conjugate vaccine-13 or pneumococcal polysaccharide vaccine-23.
In our opinion, the strengths of this study are the large sample, the prospective and consecutive data collection, the use of the current Berlin definition for ARDS, and the statistical analysis by propensity scoring to account for bias due to observed confounders. We think this study provides reliable data on the incidence of ARDS in patients with severe CAP, and that these data can be used for future studies in this important population. In addition, we assessed the association of ARDS with mortality in mechanically-ventilated patients to avoid potential bias due to worse outcomes associated with the need for ventilatory support.
Some limitations need to be addressed. First, the long period of recruitment (20 years) has undoubtedly been associated with major advances in patient care. Although we did incorporate advances in ventilatory management [10] and other support measures [13] over this time, our management protocol for CAP did not change substantially. We also allowed for this by including the period of admission when adjusting mortality outcomes. Second, this study was conducted at a single centre, which necessitates cautious extrapolation of the findings to other settings. Third, the Berlin definition requires the use of positive airway pressure, which is only applied to patients receiving ventilatory support. Fourth, the rate of respiratory viruses identified in our population may be underestimated since the diagnostic techniques employed were routinely implemented over the recruitment period.
In conclusion, ARDS complicating severe CAP occurs in 29% of ventilated patients, but is unrelated to either the aetiology or mortality. ARDS criteria should not be considered in the choice of the empiric antibiotic treatment in these patients. Abbreviations: ARDS = acute respiratory distress syndrome; CAP = community-acquired pneumonia; ICU = intensive care unit; IMV = invasive mechanical ventilation; NIMV = non-invasive mechanical ventilation. Abbreviations: ARDS = acute respiratory distress syndrome; COPD = chronic obstructive pulmonary disease. Percentages were calculated for non-missing data. a Information on previous antibiotics was obtained in 67 (89%) cases without any significant differences in the type of antibiotics each group had received: beta-lactams (38 cases), Fluoroquinolons (12 cases), Macrolides (9 cases), and other (8 cases). b Some patients may have more than 1 co-morbid condition. c Other respiratory diseases included the sequelae of pulmonary tuberculosis, pulmonary hypertension, and interstitial lung disease. Abbreviations: ARDS = acute respiratory distress syndrome; IQR = interquartile range; PaO 2 /FiO 2 = arterial oxygen tension to inspired oxygen fraction ratio; PSI = pneumonia severity index; SOFA = sepsis-related organ failure assessment. Percentages were calculated on non-missing data. a Higher SOFA in ARDS patients was due to a higher scoring in the respiratory component. b Stratified according to 30-day risk mortality for community-acquired pneumonia: risk classes I-III (≤90 points) have low predicted mortality (range, 0%-10%), and risk classes IV-V (>90 points) have the highest predicted mortality (range, 10%-35%). Abbreviations: ARDS = acute respiratory distress syndrome; ICU = intensive care unit; IQR = interquartile range. Percentages were calculated for non-missing data. Abbreviations: ARDS = acute respiratory distress syndrome; CI = confidence interval; OR = odds ratio; PSI = pneumonia severity index; SOFA = sepsis-related organ failure assessment. Data are shown as estimated ORs (95% CIs) of the explanatory variables in the 30-day mortality group. The OR is defined as the probability of 30-day mortality divided by the probability of no 30-day mortality. The p-value is based on the null hypothesis that all ORs relating to an explanatory variable equal unity (no effect). a The variables analyzed in the univariate analyses were: age, gender, influenza and pneumococcal vaccination, systemic and inhaled corticosteroids, prior
